Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|October 25, 2012
Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritisDeepak Jadon, William Tillett, Dinny Wallis, et al.
Rheumatology (Oxford, England)|November 8, 2025
A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UKCharlotte E Gollins, Annie Russell, Theresa Smith, et al.
RMD Open|September 23, 2024
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studiesM Elaine Husni, Philip J Mease, Joseph F Merola, et al.
Rheumatology and Therapy|March 13, 2022
Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower RegistryAlexis Ogdie, Kelley Myers, Carol Mansfield, et al.
Nature Reviews. Disease Primers|August 13, 2021
Psoriatic arthritisOliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Rheumatology and Therapy|July 24, 2020
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population SurveyWilliam Tillett, Joseph F Merola, Diamant Thaçi, et al.
Rheumatology and Therapy|July 4, 2021
Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 StudiesAna-Maria Orbai, M Elaine Husni, Dafna D Gladman, et al.
Clinical Medicine (London, England)|September 12, 2020
Evaluation of a patient self-stratification methodology to identify those in need of shielding during COVID-19Elizabeth Reilly, Sarah Skeoch, Sarah Hardcastle, et al.
Rheumatology and Therapy|October 28, 2021
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2HLars-Erik Kristensen, Masato Okada, William Tillett, et al.
The Journal of Rheumatology|February 1, 2025
Effect of Bimekizumab on Patient-Reported Outcomes and Work Productivity in Patients With Psoriatic Arthritis: 1-Year Results From 2 Phase III StudiesDafna D Gladman, Philip J Mease, Laure Gossec, et al.
Pageof 13